** Shares of ReNerve RNV.AX rise 9.5% to A$0.115
** Stock set for its strongest session since March 28, if current trends hold
** The medical devices maker forms a partnership with NetCentrix Ventures to establish and develop operations in the Indian healthcare market
** Co says the Indian nerve repair market currently valued at $115 million, has a growth rate of 18.5% and is expected to nearly double by 2030
** Stock down 34.3% YTD, including current session's moves
(Reporting by Manasi Dasa in Bengaluru)
((Manasi.DasaSundeep@thomsonreuters.com;))